DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Poveda A, Vergote I, Tjulandin S. et al.
Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial.

Ann Oncol 2011;
22: 39-48
doi:10.1093/annonc/mdq352

Download Bibliographical Data

Access:
Access: